Fate Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

NasdaqGM:FATE Recent Insider Transactions by Companies or Individuals
Date	Value	Name	Entity	Shares	Max Price
09 Jan 24	SellUS$62,889	J. Wolchko	Individual	14,391	US$4.37
09 Jan 24	SellUS$47,519	Cindy Tahl	Individual	10,874	US$4.37
09 Jan 24	SellUS$49,367	Bahram Valamehr	Individual	11,271	US$4.38
09 Jan 24	SellUS$30,712	Edward Dulac	Individual	7,028	US$4.37
26 Dec 23	BuyUS$6,324,000	Redmile Group, LLC	Company	1,700,000	US$3.72
26 Dec 23	BuyUS$166,024	Redmile Group, LLC	Company	44,630	US$3.72
18 Aug 23	SellUS$13,210	Edward Dulac	Individual	4,718	US$2.80
05 Jul 23	SellUS$18,769	Brian Powl	Individual	3,854	US$4.87

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of FATE?
Owner Type	Number of Shares	Ownership Percentage
Private Companies	305,233	0.268%
Individual Insiders	1,669,780	1.47%
VC/PE Firms	6,171,000	5.42%
General Public	9,041,302	7.94%
Hedge Funds	13,169,057	11.6%
Institutions	83,460,336	73.3%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 15.9%.

Top Shareholders

Top 25 shareholders own 75.47% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
11.6%	Redmile Group, LLC	13,169,057	US$62.9m	0%	2.66%
9.85%	BlackRock, Inc.	11,212,816	US$53.6m	-10.2%	no data
8.17%	The Vanguard Group, Inc.	9,293,363	US$44.4m	-14.8%	no data
5.42%	Tavistock Life Sciences	6,171,000	US$29.5m	1,130%	1.82%
4.34%	Point72 Asset Management, L.P.	4,945,146	US$23.6m	31.4%	0.05%
4.26%	Bellevue Asset Management AG	4,851,579	US$23.2m	0%	0.27%
3.15%	D. E. Shaw & Co., L.P.	3,581,979	US$17.1m	-24%	0.03%
2.97%	Johnson & Johnson Innovation - JJDC, Inc.	3,379,064	US$16.2m	0%	0.4%
2.34%	Citadel Advisors LLC	2,666,208	US$12.7m	32%	0.01%
2.3%	Jacobs Levy Equity Management Inc	2,616,820	US$12.5m	9.53%	0.06%
2%	Acadian Asset Management LLC	2,281,171	US$10.9m	6.12%	0.03%
1.92%	Monaco Asset Management S.A.M.	2,183,228	US$10.4m	18.1%	3.83%
1.8%	Casdin Capital, LLC	2,050,000	US$9.8m	0%	0.88%
1.65%	Two Sigma Advisers, LP	1,876,900	US$9.0m	-2.89%	0.02%
1.64%	Geode Capital Management, LLC	1,863,485	US$8.9m	4.96%	no data
1.64%	State Street Global Advisors, Inc.	1,861,919	US$8.9m	-18.1%	no data
1.63%	Federated Hermes, Inc.	1,849,872	US$8.8m	-24.5%	0.02%
1.49%	Adage Capital Management, L.P.	1,700,000	US$8.1m	0%	0.02%
1.43%	JP Morgan Asset Management	1,625,098	US$7.8m	-32.6%	no data
1.36%	Two Sigma Investments, LP	1,550,659	US$7.4m	-6.09%	0.02%
1.13%	Vestal Point Capital, LP	1,290,000	US$6.2m	0%	0.69%
0.96%	Morgan Stanley, Investment Banking and Brokerage Investments	1,097,331	US$5.2m	-1.87%	no data
0.86%	Charles Schwab Investment Management, Inc.	983,019	US$4.7m	0%	no data
0.79%	Integral Health Asset Management, LLC	900,000	US$4.3m	0%	0.61%
0.79%	StemPoint Capital LP	898,196	US$4.3m	0%	1.23%